Publications by authors named "D Maccubbin"

Claim this Profile
E
Effects of extended-release niacin/laropiprant on correlations between apolipoprotein B, LDL-cholesterol and non-HDL-cholesterol in patients with type 2 diabetes.
Eliot A Brinton, Joseph Triscari, Philippe Brudi, Erluo Chen, Amy O Johnson-Levonas, Darbie Maccubbin

Lipids Health Dis· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety and tolerability of extended-release niacin-laropiprant: Pooled analyses for 11,310 patients in 12 controlled clinical trials.
James McKenney, Harold Bays, Gilbert Gleim, Yale Mitchel, Olga Kuznetsova, Darbie Maccubbin

J Clin Lipidol· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-release niacin/laropiprant significantly improves lipid levels in type 2 diabetes mellitus irrespective of baseline glycemic control.
Harold E Bays, Eliot A Brinton, Joseph Triscari, Erluo Chen, Darbie Maccubbin

Vasc Health Risk Manag· October 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The association of flushing bother, impact, treatment satisfaction and discontinuation of niacin therapy.
T Rhodes, J M Norquist, C McCrary Sisk, K McQuarrie, A Trovato, D Maccubbin

Int J Clin Pract· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of niacin on the incidence of new onset diabetes and cardiovascular events in patients with normoglycaemia and impaired fasting glucose.
V Sazonov, D Maccubbin, C McCrary Sisk, P L Canner

Int J Clin Pract· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis